Trial Details
RECRUITINGBasic Information
| Clinical ID | c409 |
|---|---|
| Identifier | NCT04844606 |
| Trial Title | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Ulcerative Colitis Chronic|Inflammatory Bowel Diseases|Crohn's Disease |
| Interventions | DRUG: Mirikizumab|DRUG: Mirikizumab |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-05-26 |
|---|---|
| Primary Completion Date | 2025-07-30 |
| Completion Date | 2025-07-30 |